Share Name Share Symbol Market Type Share ISIN Share Description
Alliance Pharma LSE:APH London Ordinary Share GB0031030819 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.25p -0.52% 47.50p 47.00p 48.00p 48.00p 47.25p 47.25p 201,652.00 16:35:11
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 48.3 15.2 4.7 10.2 224.54

Alliance Pharma Share Discussion Threads

Showing 1376 to 1400 of 1400 messages
Chat Pages: 56  55  54  53  52  51  50  49  48  47  46  45  Older
DateSubjectAuthorDiscuss
21/3/2017
12:20
From April 2016: "Since completion of the acquisition in mid-December 2015, sales of Kelo-stretchTM, which had been identified as a key growth brand, have been lower than anticipated despite extensive promotional activities by A. Menarini Asia-Pacific Pte. Ltd., our key partner in South East Asia. Despite this, other Sinclair brands they distribute for us are performing well. The relationship with Menarini remains strong and other opportunities are being positively explored. The 2016 impact of the Kelo-stretch shortfall is estimated at a possible reduction of £1.2m at the operating profit level. Notwithstanding this, trading to date for the Sinclair Healthcare Products in aggregate has remained in line with management's expectations." "The fair value of intangible assets recognised on business combination comprise the following product related intangibles: Aloclair, Atopiclair, Flamma franchise, Kelo-cote, Kelo-stretch, Other Dermatology Products and Other Specialist Hospital Products." Worth keeping an eye on amortisation of intangible assets at results.
al101uk
21/3/2017
07:11
Great news £5m better off this am
nw99
13/3/2017
09:22
Buying ahead of results
nw99
01/3/2017
08:00
I agree with your views re longer term prospects but suspect that as it grows it may become a target for a larger fish.
2vdm
28/2/2017
09:50
I have added on the recent weakness. Held since early 2011 and like the long term prospects and relative stability of the business. I intend for APH to remain in my portfolio for 10yrs +
norbert colon
27/2/2017
16:53
Moderate volume and continuing fall in share price 4 day faller down 9.55% - No news. Could an II be unloading ? Looks as though going nowhere at the moment or could it be those who bought in on the Hardman reseach having stop losses triggered - Any other thoughts / knowledge ?
pugugly
25/1/2017
07:22
http://hardmanandco.com/docs/default-source/company-docs/alliance-pharma-documents/25.01.17-potential-of-diclectin.pdf?utm_source=Email+Campaign&utm_medium=email&utm_campaign=29208-372567-Alliance+Pharma+%28APH.L%29%3A+Potential+of+Diclectin
norbert colon
24/1/2017
18:11
I should have clarified that earnings will increase post 2017 as the Sinclair IS costs will have then fully passed though the business. It's a great solid business with strong mgt and one to tuck away and forget.
norbert colon
24/1/2017
17:36
Thanks Norbert. I found a bit in their RNS about primarily focusing on developing on what they've acquired so far during 2017, but useful to have some projections.Hopefully we will get more news spring/summer. I haven't been able to find a similar type of business to see if the PE is good or not, but my instinct is that this is undervalued at 49p.
2vdm
24/1/2017
14:30
Rev of £98.2m and EPS of 4p for 2017 is current forecast but may now be updated. Growth from Sinclair only really kicks in from 2017 onwards.
norbert colon
24/1/2017
14:26
Have APH set out any tgts/projected T/O P&L for this financial year? I've added today, but would be good to know where they hope to be in 12 mnths to 31st Dec 17.
2vdm
23/1/2017
23:03
Thanks Norbert for that link, all sounds good news and very promising
buying
23/1/2017
15:20
http://www.proactiveinvestors.co.uk/companies/stocktube/6780/-it-s-never-been-so-busy-and-exciting-says-alliance-pharma-plc-ceo-6780.html
norbert colon
23/1/2017
11:07
A growing company, a progressive dividend, modest pe,all in all very happy to hold this share
buying
23/1/2017
07:38
Very strong pre-closing statement this morning. The Sinclair acquisition is transforming the business. Well done to the BOD.
2vdm
18/1/2017
16:31
Looks as though reversing - Could 40p be on the books ?
pugugly
10/1/2017
16:44
big trades end of day! lets break 50p!
rolo7
21/12/2016
12:12
Moving up again, employee share options being exercised a big clue. Big revenue from outside uk nice fx gains.
rolo7
16/12/2016
15:46
Looks like we are heading back to the 50s.
paqman
12/12/2016
23:38
added 20 here, so many takeovers around big fx gains to be made as 50% sales overseas, note the employee share options being exercised.
rolo7
07/11/2016
15:35
Any more on this ACAS tribunal i can not find any info any were on the matter ? the one site i did find something about it on the info seems to have gone already shorter,s at work or real news ?
ddbsba
24/10/2016
22:23
Alliance Pharma plc today is reported to ACAS for tribuneral in UK 47p at the moment, maybe 20 in few months...
spiro1
11/10/2016
11:37
Alliance Pharma CEO John Dawson will be presenting to investors at the Proactive One2One forum on 20th October in Mayfair, London. To register to attend, please click here http://tinyurl.com/jytrhr3.
aim_trader
30/9/2016
11:09
hard work here
cool hand kev
29/9/2016
16:03
Seems to be trending up again
buying
Chat Pages: 56  55  54  53  52  51  50  49  48  47  46  45  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:42 V: D:20170322 22:05:00